Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Mar 28;20(1):134.
doi: 10.1186/s12891-019-2502-7.

Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients

Affiliations
Comparative Study

Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients

Georg W Omlor et al. BMC Musculoskelet Disord. .

Abstract

Background: Sufficient data on outcome of patients with clinically and radiologically aggressive enchondromas and atypical cartilaginous tumors (ACT) is lacking. We therefore analyzed both conservatively and surgically treated patients with lesions, which were not distinguishable between benign enchondroma and low-grade malignant ACT based upon clinical and radiologic appearance.

Methods: The series included 228 consecutive cases with a follow-up > 24 months to assess radiological, histological, and clinical outcome including recurrences and complications. Pain, satisfaction, functional limitations, and the musculoskeletal tumor society (MSTS) score were evaluated to judge both function and emotional acceptance at final follow-up.

Results: Follow-up took place at a mean of 82 (median 75) months. The 228 patients all had comparable clinical and radiological findings. Of these, 153 patients were treated conservatively, while the other 75 patients underwent intralesional curettage. Besides clinical and radiological aggressiveness, most lesions were histologically judged as benign enchondromas. 9 cases were determined to be ACT, while the remaining 7 cases had indeterminate histology. After surgery, three patients developed a recurrence, and a further seven had complications of which six were related to osteosynthesis. Both groups had excellent and almost equal MSTS scores of 96 and 97%, respectively, but significantly less functional limitations were found in the non-surgery group. Further sub-analyses were performed to reduce selection bias. Sub-analysis of histologically diagnosed enchondromas in the surgery group found more pain, less function, and worse MSTS score compared to the non-surgery group. Sub-analysis of smaller lesions (< 4.4 cm) did not show significant differences. In contrast, larger lesions displayed significantly worse results after surgery compared to conservative treatment (enchondromas > 4.4 cm: MSTS score: 94.0% versus 97.3%, p = 0.007; pain 2.3 versus 0.8, p = 0.001). The majority of lesions treated surgically was filled with polymethylmethacrylate bone-cement, while the remainder was filled with cancellous-bone, without significant difference in clinical outcome.

Conclusion: Feasibility of intralesional curettage strategies for symptomatic benign to low-grade malignant chondrogenic tumors was supported. Surgery, however, did not prove superior compared to conservative clinical and radiological observation. Due to the low risk of transformation into higher-grade tumors and better functional results, more lesions might just be observed if continuous follow-up is assured.

Keywords: ACT; Bone-cement; Chondrosarcoma; Curettage; Enchondroma; Long bones.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Approval was given by our ethical committee of the University of Heidelberg, Germany (votum number S-053/2017). Informed written consent was obtained from all patients. For patients younger than 18-years written consent was obtained on their behalf by a parent/legal guardian.

Consent for publication

not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Surgical treatment at the proximal humerus Typical chondroid matrix (white arrows) is visible in ap x-ray (a) and coronal (c) and axial (d) T1 dotarem contrast-enhanced MRI. The decision to perform surgery was made due to local pain, lesion size and radiological signs of aggressiveness with endosteal scalloping (red arrows). After rigorous intralesional curettage and use of a high-speed burr, the lesion was filled with polymethylmethacrylate bone-cement (yellow arrows in b, e, and f).
Fig. 2
Fig. 2
Surgical treatment at the proximal tibia Typical chondroid matrix (white arrows) and endosteal scalloping (red arrows) is visible in ap x-ray (a) and coronal (b) and axial (c) T1 dotarem contrast-enhanced MRI. As a result of the large biomechanical stresses on the lesion location, a compound osteosynthesis using polymethylmethacrylate bone-cement and a plate (yellow arrows in ap (d) and lateral (e) x-rays) was performed after rigorous curettage and use of a high-speed burr.
Fig. 3
Fig. 3
Conservative treatment at the proximal humerus Typical chondroid matrix (white arrows) is visible in ap X-ray (a) and axial (b), coronal (c), and sagittal (d) T1 dotarem contrast-enhanced MRI. Local pain, size and radiological signs of aggressiveness with endosteal scalloping (red arrows) caused presentation and follow-up in our orthopaedic oncology department. The patient declined surgical excision, and was regularly followed-up with MRI and x-ray to rule out significant tumor growth or increase in endosteal scalloping.
Fig. 4
Fig. 4
Conservative treatment at the distal femur Typical chondroid matrix (white arrows) is visible in ap (a) and lateral (b) X-rays and coronal (c) and axial (d) T1 dotarem contrast-enhanced MRI. Despite local pain, large lesion size, and endosteal scalloping (red arrows) surgery was not performed.
Fig. 5
Fig. 5
Box plots comparing lesion sizes of the surgery and the non-surgery group for the whole collective including all lesion sizes (a) and for lesions with tumor sizes < 4.4 cm (b) or > 4.4 cm (c)

References

    1. Rozeman LB, Cleton-Jansen AM. Pathology of primary malignant bone and cartilage tumours. Int Orthop. 2006;30:437–444. doi: 10.1007/s00264-006-0212-x. - DOI - PMC - PubMed
    1. Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. 2014;46:95–104. doi: 10.1097/PAT.0000000000000050. - DOI - PubMed
    1. Altay M, Bayrakci K, Yildiz Y, Erekul S, Saglik Y. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients. J Orthop Sci. 2007;2:415–423. doi: 10.1007/s00776-007-1152-z. - DOI - PubMed
    1. Deckers C, Schreuder BH, Hannink G, de Rooy JW, van der Geest IC. Radiologic follow-up of untreated enchondroma and atypical cartilaginous tumors in the long bones. J Surg Oncol. 2016;114:987–991. doi: 10.1002/jso.24465. - DOI - PMC - PubMed
    1. Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998;18:1213–1237. doi: 10.1148/radiographics.18.5.9747616. - DOI - PubMed

Publication types

MeSH terms